1. Home
  2. VTSI vs ELUT Comparison

VTSI vs ELUT Comparison

Compare VTSI & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$3.26

Market Cap

51.0M

ML Signal

HOLD

ELUT

Elutia Inc.

HOLD

Current Price

$1.02

Market Cap

48.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
ELUT
Founded
1993
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
48.3M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
VTSI
ELUT
Price
$3.26
$1.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$6.00
AVG Volume (30 Days)
64.8K
121.9K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.77
EPS
N/A
0.87
Revenue
$185,971.00
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$27.30
$10.83
P/E Ratio
N/A
$1.21
Revenue Growth
N/A
N/A
52 Week Low
$3.16
$0.50
52 Week High
$7.47
$2.60

Technical Indicators

Market Signals
Indicator
VTSI
ELUT
Relative Strength Index (RSI) 22.65 44.52
Support Level N/A $1.00
Resistance Level $4.75 $1.18
Average True Range (ATR) 0.26 0.07
MACD -0.15 0.00
Stochastic Oscillator 5.21 31.82

Price Performance

Historical Comparison
VTSI
ELUT

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of judgmental use-of-force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company operates in six segments, which include Simulators and Accessories, Extended Service, Customized software and Custom content, Installation and Training, Design and Prototyping, and Subscription Training Equipment Partnership. The majority of its revenue is generated from the Simulators and Accessories segment.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: